High-Resolution Melting Analysis Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has recently released an in-depth analysis of the High-Resolution Melting Analysis (HRMA) Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the structure of the HRMA market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.

The global high-resolution melting analysis market is forecast to expand at a CAGR of 3.1% and thereby increase from US$289.4 Mn in 2023, to US$358.4 Mn by the end of 2030.

Key Insights:

HRMA Market Size (2023E): USD 289.4 Million
Projected Market Value (2030F): US$ 358.4 Million
Global Market Growth Rate (CAGR 2023 to 2030): 3.1%
Historical Market Growth Rate (CAGR 2018 to 2022): 3.0%

HRMA Market - Report Scope:

The HRMA market offers advanced solutions for the analysis of nucleic acid sequences, providing researchers and clinicians with precise tools for genotyping, mutation scanning, and methylation analysis. HRMA technology leverages the unique properties of DNA melting curves to detect sequence variations and genetic abnormalities with high sensitivity and specificity. Market growth is driven by the expanding applications of HRMA in molecular diagnostics, pharmaceutical research, and forensic analysis. The versatility, accuracy, and cost-effectiveness of HRMA make it a preferred choice for genetic analysis across diverse fields, fueling market expansion.

Market Growth Drivers:

The global HRMA market is propelled by the increasing prevalence of genetic disorders, infectious diseases, and cancer, driving demand for rapid and reliable molecular diagnostic techniques. HRMA offers several advantages over traditional methods, including real-time detection, high-throughput capabilities, and compatibility with various sample types. Additionally, advancements in HRMA instrumentation and software algorithms enhance assay performance, enabling accurate detection of genetic mutations, polymorphisms, and epigenetic modifications. The growing adoption of personalized medicine and precision oncology further augments the demand for HRMA platforms, facilitating genotype-guided treatment decisions and therapeutic interventions.

Market Restraints:

Despite significant growth prospects, the HRMA market faces challenges related to assay standardization, data interpretation, and competition from alternative technologies. Standardizing HRMA assays across different laboratories and instruments poses technical and logistical challenges, potentially affecting assay reproducibility and inter-laboratory consistency. Moreover, interpreting HRMA data requires expertise in curve analysis and bioinformatics, necessitating specialized training and software tools. Additionally, alternative molecular diagnostic techniques, such as next-generation sequencing (NGS) and digital PCR (dPCR), offer complementary advantages in terms of sequencing depth, absolute quantification, and multiplexing capabilities, posing competition for HRMA-based assays.

Market Opportunities:

The global HRMA market stands poised to capitalize on emerging opportunities in precision medicine, companion diagnostics, and point-of-care testing. As healthcare systems shift towards personalized approaches to disease management, there is an increasing demand for rapid and cost-effective molecular diagnostic tools that can guide treatment decisions and monitor therapeutic responses. HRMA platforms offer potential applications in pharmacogenomics, infectious disease genotyping, and cancer biomarker analysis, facilitating the development of targeted therapies and companion diagnostic tests. Moreover, the miniaturization and automation of HRMA systems enable decentralized testing in resource-limited settings, expanding access to molecular diagnostics and improving patient outcomes.

Key Questions Answered in the Report:

Which regions are expected to dominate the HRMA market in the future?
What are the primary factors driving the adoption of HRMA technology in molecular diagnostics and research applications?
How will ongoing technological advancements and regulatory developments impact the global HRMA market?
Who are the key players contributing to the HRMA market, and what strategies are they employing to gain a competitive edge?
What are the key application areas and emerging trends shaping the landscape of the HRMA market?

Competitive Landscape and Business Strategy:

Major players in the global HRMA market, such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and QIAGEN N.V., prioritize innovation and strategic partnerships to maintain market leadership. These companies invest significantly in research and development to enhance HRMA instrument performance, develop novel assay chemistries, and expand assay menus. Furthermore, strategic collaborations with academic institutions, clinical laboratories, and pharmaceutical companies enable market players to validate HRMA assays for specific applications, broaden market reach, and foster technology adoption. By leveraging their technological expertise, global distribution networks, and regulatory capabilities, market leaders can capitalize on emerging opportunities and address evolving customer needs in the dynamic molecular diagnostics landscape.

Key Companies Profiled:

Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
F. Hoffman-La Roche Ltd.
Bio Farma
QIAGEN
Illumina, Inc.
Agilent Technologies, Inc.
BIOMERIEUX
Meridian Bioscience, Inc.
Novacyt
PREMIER Biosoft
Azura Genomics Inc.
Canon Medical Systems Corporation

HRMA Market Research Segmentation:

The HRMA market is segmented based on various parameters, including product type, application, end-user, and region.

By Product:

Reagents
Instruments
Software

By Application:

Detection of Acquired Mutations/Mutation Scanning/SNP Typing
Microbial Species Identification
Zygosity Testing
Epigenetics/Methylation Profiling and Drug-Resistant

By End User:

Academic Research
Clinical Diagnostics

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33995

1. Executive Summary

1.1. Global High-Resolution Melting Analysis Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. High-Resolution Melting Analysis Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global High-Resolution Melting Analysis Market Outlook: Product
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  - 3.3.3.1. Reagents
  - 3.3.3.2. Instruments
  - 3.3.3.3. Software
3.4. Market Attractiveness Analysis: Product
3.5. Global High-Resolution Melting Analysis Market Outlook: End User
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.5.3.1. Academic Research
  - 3.5.3.2. Clinical Diagnostics
3.6. Market Attractiveness Analysis: End User
3.7. Global High-Resolution Melting Analysis Market Outlook: Application
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  - 3.7.3.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
  - 3.7.3.2. Microbial Species Identification
  - 3.7.3.3. Zygosity Testing
  - 3.7.3.4. Epigenetics/Methylation Profiling and Drug-Resistant
3.8. Market Attractiveness Analysis: Application

4. Global High-Resolution Melting Analysis Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Product
- 5.3.3. By End User
- 5.3.4. By Application
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 5.5.1. Reagents
- 5.5.2. Instruments
- 5.5.3. Software
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.6.1. Academic Research
- 5.6.2. Clinical Diagnostics
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 5.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
- 5.7.2. Microbial Species Identification
- 5.7.3. Zygosity Testing
- 5.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
5.8. Market Attractiveness Analysis

6. Europe High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Product
- 6.3.3. By End User
- 6.3.4. By Application
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 6.5.1. Reagents
- 6.5.2. Instruments
- 6.5.3. Software
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.6.1. Academic Research
- 6.6.2. Clinical Diagnostics
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 6.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
- 6.7.2. Microbial Species Identification
- 6.7.3. Zygosity Testing
- 6.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
6.8. Market Attractiveness Analysis

7. East Asia High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Product
- 7.3.3. By End User
- 7.3.4. By Application
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 7.5.1. Reagents
- 7.5.2. Instruments
- 7.5.3. Software
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.6.1. Academic Research
- 7.6.2. Clinical Diagnostics
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 7.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
- 7.7.2. Microbial Species Identification
- 7.7.3. Zygosity Testing
- 7.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
7.8. Market Attractiveness Analysis

8. South Asia & Oceania High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Product
- 8.3.3. By End User
- 8.3.4. By Application
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 8.5.1. Reagents
- 8.5.2. Instruments
- 8.5.3. Software
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.6.1. Academic Research
- 8.6.2. Clinical Diagnostics
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 8.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
- 8.7.2. Microbial Species Identification
- 8.7.3. Zygosity Testing
- 8.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
8.8. Market Attractiveness Analysis

9. Latin America High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis ByMarket, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Product
- 9.3.3. By End User
- 9.3.4. By Application
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 9.5.1. Reagents
- 9.5.2. Instruments
- 9.5.3. Software
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.6.1. Academic Research
- 9.6.2. Clinical Diagnostics
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 9.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
- 9.7.2. Microbial Species Identification
- 9.7.3. Zygosity Testing
- 9.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
9.8. Market Attractiveness Analysis

10. Middle East & Africa High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Product
- 10.3.3. By End User
- 10.3.4. By Application
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 10.5.1. Reagents
- 10.5.2. Instruments
- 10.5.3. Software
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.6.1. Academic Research
- 10.6.2. Clinical Diagnostics
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 10.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
- 10.7.2. Microbial Species Identification
- 10.7.3. Zygosity Testing
- 10.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Thermo Fisher Scientific Inc.
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Bio-Rad Laboratories, Inc.
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. F. Hoffman-La Roche Ltd.
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Bio Farma
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. QIAGEN
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Illumina, Inc.
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Agilent Technologies, Inc.
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. BIOMERIEUX
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Meridian Bioscience, Inc.
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. Novacyt
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. PREMIER Biosoft
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Product
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy
- 11.3.12. Azura Genomics Inc.
  - 11.3.12.1. Overview
  - 11.3.12.2. Segments and Product
  - 11.3.12.3. Key Financials
  - 11.3.12.4. Market Developments
  - 11.3.12.5. Market Strategy
- 11.3.13. Canon Medical Systems Corporation
  - 11.3.13.1. Overview
  - 11.3.13.2. Segments and Product
  - 11.3.13.3. Key Financials
  - 11.3.13.4. Market Developments
  - 11.3.13.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations